Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etomidate Induction Dose and BIS Monitoring
NCT05862753Completed
- Sponsor
- Erasmus Hospital
- Start
- Jan 2022
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of etomidate in Anesthesia, sponsored by Erasmus Hospital. Primary endpoints: Time to loss of consciousness and Time to loss of palpebral reflex. Started Jan 2022; status: completed.
02
Drugs
etomidate
03
Conditions
Anesthesia
Beyond the preview
Go deeper on NCT05862753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05862753.